These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8183257)

  • 1. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity.
    Kolb NS; Hunsaker LA; Vander Jagt DL
    Mol Pharmacol; 1994 Apr; 45(4):797-801. PubMed ID: 8183257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE; Lai CJ
    Arch Biochem Biophys; 1996 Mar; 327(1):89-97. PubMed ID: 8615700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T; Petrash JM
    Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S; Das B; Srivastava SK
    Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities.
    Rees-Milton KJ; Jia Z; Green NC; Bhatia M; El-Kabbani O; Flynn TG
    Arch Biochem Biophys; 1998 Jul; 355(2):137-44. PubMed ID: 9675019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of aldose reductase and aldehyde reductase from human kidney.
    Ansari NH; Bhatnagar A; Liu SQ; Srivastava SK
    Biochem Int; 1991 Nov; 25(4):755-65. PubMed ID: 1815509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
    El-Kabbani O; Old SE; Ginell SL; Carper DA
    Mol Vis; 1999 Sep; 5():20. PubMed ID: 10493777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human kidney aldose and aldehyde reductases.
    Sato S; Kador PF
    J Diabetes Complications; 1993; 7(3):179-87. PubMed ID: 8343612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase is a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol, in human and animal adrenal glands.
    Matsuura K; Deyashiki Y; Bunai Y; Ohya I; Hara A
    Arch Biochem Biophys; 1996 Apr; 328(2):265-71. PubMed ID: 8645003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of aldose reductase activity. Mechanism of action of an activated form of the enzyme].
    Pavlov AR; Vartanov SS; Iaropolov AI
    Biokhimiia; 1992 Mar; 57(3):378-88. PubMed ID: 1344193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of aldose reductase inhibitors in vitro. Effects of enzyme purification and substrate type.
    Poulsom R
    Biochem Pharmacol; 1987 May; 36(10):1577-81. PubMed ID: 3109423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal loop of aldehyde reductase determines the substrate and inhibitor specificity.
    Barski OA; Gabbay KH; Bohren KM
    Biochemistry; 1996 Nov; 35(45):14276-80. PubMed ID: 8916913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation of crystalline lens aldose reductase activity. Nonhyperbolic oxidation kinetics of NADPH by glucose].
    Vartanov SS; Pavlov AR; Iaropolov AI
    Biokhimiia; 1990 Nov; 55(11):2046-57. PubMed ID: 2128191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide.
    Parekh HK; Sladek NE
    Biochem Pharmacol; 1993 Sep; 46(6):1043-52. PubMed ID: 8216347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications.
    Vander Jagt DL; Robinson B; Taylor KK; Hunsaker LA
    J Biol Chem; 1992 Mar; 267(7):4364-9. PubMed ID: 1537826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a role for a mouse sperm surface aldo-keto reductase (AKR1B7) and its human analogue in the detoxification of the reactive aldehyde, acrolein.
    Jagoe WN; Howe K; O'Brien SC; Carroll J
    Andrologia; 2013 Oct; 45(5):326-31. PubMed ID: 22970857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldose reductase activation is a key component of myocardial response to ischemia.
    Hwang YC; Sato S; Tsai JY; Yan S; Bakr S; Zhang H; Oates PJ; Ramasamy R
    FASEB J; 2002 Feb; 16(2):243-5. PubMed ID: 11772943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and kinetic determinants of aldehyde reduction by aldose reductase.
    Srivastava S; Watowich SJ; Petrash JM; Srivastava SK; Bhatnagar A
    Biochemistry; 1999 Jan; 38(1):42-54. PubMed ID: 9890881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase from human skeletal and heart muscle. Interconvertible forms related by thiol-disulfide exchange.
    Vander Jagt DL; Robinson B; Taylor KK; Hunsaker LA
    J Biol Chem; 1990 Dec; 265(34):20982-7. PubMed ID: 2174432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of non-enzymatic glycation on recombinant human aldose reductase.
    Yamaoka T; Oda A; Bannai C; Itakura M; Yamashita K
    Diabetes Res Clin Pract; 1995 Mar; 27(3):165-9. PubMed ID: 7555597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.